Global CGRP Targeting Drugs for Migraine Market Growth (Status and Outlook) 2026-2032

July 2026 | 91 pages | ID: G4BEB56E6FA8EN
LP Information

Abstracts

The global CGRP Targeting Drugs for Migraine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The main principle of drugs targeting CGRP for Migraine is to inhibit the biological effects of CGRP by blocking the binding of CGRP to its receptors, thereby achieving the purpose of treatment.

United States market for CGRP Targeting Drugs for Migraine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for CGRP Targeting Drugs for Migraine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for CGRP Targeting Drugs for Migraine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key CGRP Targeting Drugs for Migraine players cover AbbVie Inc., Pfizer Inc., Lundbeck, Alder Therapeutics, Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?CGRP Targeting Drugs for Migraine Industry Forecast? looks at past sales and reviews total world CGRP Targeting Drugs for Migraine sales in 2025, providing a comprehensive analysis by region and market sector of projected CGRP Targeting Drugs for Migraine sales for 2026 through 2032. With CGRP Targeting Drugs for Migraine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CGRP Targeting Drugs for Migraine industry.

This Insight Report provides a comprehensive analysis of the global CGRP Targeting Drugs for Migraine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CGRP Targeting Drugs for Migraine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global CGRP Targeting Drugs for Migraine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CGRP Targeting Drugs for Migraine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CGRP Targeting Drugs for Migraine.

This report presents a comprehensive overview, market shares, and growth opportunities of CGRP Targeting Drugs for Migraine market by product type, application, key players and key regions and countries.

Segmentation by Type:

• CGRP Receptor Antagonists
• CGRP Monoclonal Antibodies

Segmentation by Application:

• Hospital
• Specialty Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AbbVie Inc.
• Pfizer Inc.
• Lundbeck
• Alder Therapeutics
• Teva
• Lilly Inc.
• Amgen Inc.
• Novartis International AG
• Daiichi Sankyo Co., Ltd.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global CGRP Targeting Drugs for Migraine Market Size (2021-2032)
  2.1.2 CGRP Targeting Drugs for Migraine Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for CGRP Targeting Drugs for Migraine by Country/Region (2021, 2025 & 2032)
2.2 CGRP Targeting Drugs for Migraine Segment by Type
  2.2.1 CGRP Receptor Antagonists
  2.2.2 CGRP Monoclonal Antibodies
  2.2.3 CGRP Targeting Drugs for Migraine Market Size by Type
    2.2.3.1 CGRP Targeting Drugs for Migraine Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global CGRP Targeting Drugs for Migraine Market Size Market Share by Type (2021-2026)
2.3 CGRP Targeting Drugs for Migraine Segment by Application
  2.3.1 Hospital
  2.3.2 Specialty Clinic
  2.3.3 Others
  2.3.4 CGRP Targeting Drugs for Migraine Market Size by Application
    2.3.4.1 CGRP Targeting Drugs for Migraine Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global CGRP Targeting Drugs for Migraine Market Size Market Share by Application (2021-2026)

3 CGRP TARGETING DRUGS FOR MIGRAINE MARKET SIZE BY PLAYER

3.1 CGRP Targeting Drugs for Migraine Market Size Market Share by Player
  3.1.1 Global CGRP Targeting Drugs for Migraine Revenue by Player (2021-2026)
  3.1.2 Global CGRP Targeting Drugs for Migraine Revenue Market Share by Player (2021-2026)
3.2 Global CGRP Targeting Drugs for Migraine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CGRP TARGETING DRUGS FOR MIGRAINE BY REGION

4.1 CGRP Targeting Drugs for Migraine Market Size by Region (2021-2026)
4.2 Global CGRP Targeting Drugs for Migraine Annual Revenue by Country/Region (2021-2026)
4.3 Americas CGRP Targeting Drugs for Migraine Market Size Growth (2021-2026)
4.4 APAC CGRP Targeting Drugs for Migraine Market Size Growth (2021-2026)
4.5 Europe CGRP Targeting Drugs for Migraine Market Size Growth (2021-2026)
4.6 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas CGRP Targeting Drugs for Migraine Market Size by Country (2021-2026)
5.2 Americas CGRP Targeting Drugs for Migraine Market Size by Type (2021-2026)
5.3 Americas CGRP Targeting Drugs for Migraine Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC CGRP Targeting Drugs for Migraine Market Size by Region (2021-2026)
6.2 APAC CGRP Targeting Drugs for Migraine Market Size by Type (2021-2026)
6.3 APAC CGRP Targeting Drugs for Migraine Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe CGRP Targeting Drugs for Migraine Market Size by Country (2021-2026)
7.2 Europe CGRP Targeting Drugs for Migraine Market Size by Type (2021-2026)
7.3 Europe CGRP Targeting Drugs for Migraine Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa CGRP Targeting Drugs for Migraine by Region (2021-2026)
8.2 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Type (2021-2026)
8.3 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CGRP TARGETING DRUGS FOR MIGRAINE MARKET FORECAST

10.1 Global CGRP Targeting Drugs for Migraine Forecast by Region (2027-2032)
  10.1.1 Global CGRP Targeting Drugs for Migraine Forecast by Region (2027-2032)
  10.1.2 Americas CGRP Targeting Drugs for Migraine Forecast
  10.1.3 APAC CGRP Targeting Drugs for Migraine Forecast
  10.1.4 Europe CGRP Targeting Drugs for Migraine Forecast
  10.1.5 Middle East & Africa CGRP Targeting Drugs for Migraine Forecast
10.2 Americas CGRP Targeting Drugs for Migraine Forecast by Country (2027-2032)
  10.2.1 United States Market CGRP Targeting Drugs for Migraine Forecast
  10.2.2 Canada Market CGRP Targeting Drugs for Migraine Forecast
  10.2.3 Mexico Market CGRP Targeting Drugs for Migraine Forecast
  10.2.4 Brazil Market CGRP Targeting Drugs for Migraine Forecast
10.3 APAC CGRP Targeting Drugs for Migraine Forecast by Region (2027-2032)
  10.3.1 China CGRP Targeting Drugs for Migraine Market Forecast
  10.3.2 Japan Market CGRP Targeting Drugs for Migraine Forecast
  10.3.3 Korea Market CGRP Targeting Drugs for Migraine Forecast
  10.3.4 Southeast Asia Market CGRP Targeting Drugs for Migraine Forecast
  10.3.5 India Market CGRP Targeting Drugs for Migraine Forecast
  10.3.6 Australia Market CGRP Targeting Drugs for Migraine Forecast
10.4 Europe CGRP Targeting Drugs for Migraine Forecast by Country (2027-2032)
  10.4.1 Germany Market CGRP Targeting Drugs for Migraine Forecast
  10.4.2 France Market CGRP Targeting Drugs for Migraine Forecast
  10.4.3 UK Market CGRP Targeting Drugs for Migraine Forecast
  10.4.4 Italy Market CGRP Targeting Drugs for Migraine Forecast
  10.4.5 Russia Market CGRP Targeting Drugs for Migraine Forecast
10.5 Middle East & Africa CGRP Targeting Drugs for Migraine Forecast by Region (2027-2032)
  10.5.1 Egypt Market CGRP Targeting Drugs for Migraine Forecast
  10.5.2 South Africa Market CGRP Targeting Drugs for Migraine Forecast
  10.5.3 Israel Market CGRP Targeting Drugs for Migraine Forecast
  10.5.4 Turkey Market CGRP Targeting Drugs for Migraine Forecast
10.6 Global CGRP Targeting Drugs for Migraine Forecast by Type (2027-2032)
10.7 Global CGRP Targeting Drugs for Migraine Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market CGRP Targeting Drugs for Migraine Forecast

11 KEY PLAYERS ANALYSIS

11.1 AbbVie Inc.
  11.1.1 AbbVie Inc. Company Information
  11.1.2 AbbVie Inc. CGRP Targeting Drugs for Migraine Product Offered
  11.1.3 AbbVie Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 AbbVie Inc. Main Business Overview
  11.1.5 AbbVie Inc. Latest Developments
11.2 Pfizer Inc.
  11.2.1 Pfizer Inc. Company Information
  11.2.2 Pfizer Inc. CGRP Targeting Drugs for Migraine Product Offered
  11.2.3 Pfizer Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Pfizer Inc. Main Business Overview
  11.2.5 Pfizer Inc. Latest Developments
11.3 Lundbeck
  11.3.1 Lundbeck Company Information
  11.3.2 Lundbeck CGRP Targeting Drugs for Migraine Product Offered
  11.3.3 Lundbeck CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Lundbeck Main Business Overview
  11.3.5 Lundbeck Latest Developments
11.4 Alder Therapeutics
  11.4.1 Alder Therapeutics Company Information
  11.4.2 Alder Therapeutics CGRP Targeting Drugs for Migraine Product Offered
  11.4.3 Alder Therapeutics CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Alder Therapeutics Main Business Overview
  11.4.5 Alder Therapeutics Latest Developments
11.5 Teva
  11.5.1 Teva Company Information
  11.5.2 Teva CGRP Targeting Drugs for Migraine Product Offered
  11.5.3 Teva CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Teva Main Business Overview
  11.5.5 Teva Latest Developments
11.6 Lilly Inc.
  11.6.1 Lilly Inc. Company Information
  11.6.2 Lilly Inc. CGRP Targeting Drugs for Migraine Product Offered
  11.6.3 Lilly Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Lilly Inc. Main Business Overview
  11.6.5 Lilly Inc. Latest Developments
11.7 Amgen Inc.
  11.7.1 Amgen Inc. Company Information
  11.7.2 Amgen Inc. CGRP Targeting Drugs for Migraine Product Offered
  11.7.3 Amgen Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Amgen Inc. Main Business Overview
  11.7.5 Amgen Inc. Latest Developments
11.8 Novartis International AG
  11.8.1 Novartis International AG Company Information
  11.8.2 Novartis International AG CGRP Targeting Drugs for Migraine Product Offered
  11.8.3 Novartis International AG CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Novartis International AG Main Business Overview
  11.8.5 Novartis International AG Latest Developments
11.9 Daiichi Sankyo Co., Ltd.
  11.9.1 Daiichi Sankyo Co., Ltd. Company Information
  11.9.2 Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Product Offered
  11.9.3 Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Daiichi Sankyo Co., Ltd. Main Business Overview
  11.9.5 Daiichi Sankyo Co., Ltd. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. CGRP Targeting Drugs for Migraine Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CGRP Targeting Drugs for Migraine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of CGRP Receptor Antagonists
Table 4. Major Players of CGRP Monoclonal Antibodies
Table 5. CGRP Targeting Drugs for Migraine Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global CGRP Targeting Drugs for Migraine Market Size by Type (2021-2026) & ($ millions)
Table 7. Global CGRP Targeting Drugs for Migraine Market Size Market Share by Type (2021-2026)
Table 8. CGRP Targeting Drugs for Migraine Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global CGRP Targeting Drugs for Migraine Market Size by Application (2021-2026) & ($ millions)
Table 10. Global CGRP Targeting Drugs for Migraine Market Size Market Share by Application (2021-2026)
Table 11. Global CGRP Targeting Drugs for Migraine Revenue by Player (2021-2026) & ($ millions)
Table 12. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Player (2021-2026)
Table 13. CGRP Targeting Drugs for Migraine Key Players Head office and Products Offered
Table 14. CGRP Targeting Drugs for Migraine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CGRP Targeting Drugs for Migraine Market Size by Region (2021-2026) & ($ millions)
Table 18. Global CGRP Targeting Drugs for Migraine Market Size Market Share by Region (2021-2026)
Table 19. Global CGRP Targeting Drugs for Migraine Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas CGRP Targeting Drugs for Migraine Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas CGRP Targeting Drugs for Migraine Market Size Market Share by Country (2021-2026)
Table 23. Americas CGRP Targeting Drugs for Migraine Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas CGRP Targeting Drugs for Migraine Market Size Market Share by Type (2021-2026)
Table 25. Americas CGRP Targeting Drugs for Migraine Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas CGRP Targeting Drugs for Migraine Market Size Market Share by Application (2021-2026)
Table 27. APAC CGRP Targeting Drugs for Migraine Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC CGRP Targeting Drugs for Migraine Market Size Market Share by Region (2021-2026)
Table 29. APAC CGRP Targeting Drugs for Migraine Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC CGRP Targeting Drugs for Migraine Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe CGRP Targeting Drugs for Migraine Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe CGRP Targeting Drugs for Migraine Market Size Market Share by Country (2021-2026)
Table 33. Europe CGRP Targeting Drugs for Migraine Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe CGRP Targeting Drugs for Migraine Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CGRP Targeting Drugs for Migraine
Table 39. Key Market Challenges & Risks of CGRP Targeting Drugs for Migraine
Table 40. Key Industry Trends of CGRP Targeting Drugs for Migraine
Table 41. Global CGRP Targeting Drugs for Migraine Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global CGRP Targeting Drugs for Migraine Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global CGRP Targeting Drugs for Migraine Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global CGRP Targeting Drugs for Migraine Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. AbbVie Inc. Details, Company Type, CGRP Targeting Drugs for Migraine Area Served and Its Competitors
Table 46. AbbVie Inc. CGRP Targeting Drugs for Migraine Product Offered
Table 47. AbbVie Inc. CGRP Targeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. AbbVie Inc. Main Business
Table 49. AbbVie Inc. Latest Developments
Table 50. Pfizer Inc. Details, Company Type, CGRP Targeting Drugs for Migraine Area Served and Its Competitors
Table 51. Pfizer Inc. CGRP Targeting Drugs for Migraine Product Offered
Table 52. Pfizer Inc. CGRP Targeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Pfizer Inc. Main Business
Table 54. Pfizer Inc. Latest Developments
Table 55. Lundbeck Details, Company Type, CGRP Targeting Drugs for Migraine Area Served and Its Competitors
Table 56. Lundbeck CGRP Targeting Drugs for Migraine Product Offered
Table 57. Lundbeck CGRP Targeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Lundbeck Main Business
Table 59. Lundbeck Latest Developments
Table 60. Alder Therapeutics Details, Company Type, CGRP Targeting Drugs for Migraine Area Served and Its Competitors
Table 61. Alder Therapeutics CGRP Targeting Drugs for Migraine Product Offered
Table 62. Alder Therapeutics CGRP Targeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Alder Therapeutics Main Business
Table 64. Alder Therapeutics Latest Developments
Table 65. Teva Details, Company Type, CGRP Targeting Drugs for Migraine Area Served and Its Competitors
Table 66. Teva CGRP Targeting Drugs for Migraine Product Offered
Table 67. Teva CGRP Targeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Teva Main Business
Table 69. Teva Latest Developments
Table 70. Lilly Inc. Details, Company Type, CGRP Targeting Drugs for Migraine Area Served and Its Competitors
Table 71. Lilly Inc. CGRP Targeting Drugs for Migraine Product Offered
Table 72. Lilly Inc. CGRP Targeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Lilly Inc. Main Business
Table 74. Lilly Inc. Latest Developments
Table 75. Amgen Inc. Details, Company Type, CGRP Targeting Drugs for Migraine Area Served and Its Competitors
Table 76. Amgen Inc. CGRP Targeting Drugs for Migraine Product Offered
Table 77. Amgen Inc. CGRP Targeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Amgen Inc. Main Business
Table 79. Amgen Inc. Latest Developments
Table 80. Novartis International AG Details, Company Type, CGRP Targeting Drugs for Migraine Area Served and Its Competitors
Table 81. Novartis International AG CGRP Targeting Drugs for Migraine Product Offered
Table 82. Novartis International AG CGRP Targeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Novartis International AG Main Business
Table 84. Novartis International AG Latest Developments
Table 85. Daiichi Sankyo Co., Ltd. Details, Company Type, CGRP Targeting Drugs for Migraine Area Served and Its Competitors
Table 86. Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Product Offered
Table 87. Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Daiichi Sankyo Co., Ltd. Main Business
Table 89. Daiichi Sankyo Co., Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. CGRP Targeting Drugs for Migraine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CGRP Targeting Drugs for Migraine Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CGRP Targeting Drugs for Migraine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CGRP Targeting Drugs for Migraine Sales Market Share by Country/Region (2025)
Figure 8. CGRP Targeting Drugs for Migraine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CGRP Targeting Drugs for Migraine Market Size Market Share by Type in 2025
Figure 10. CGRP Targeting Drugs for Migraine in Hospital
Figure 11. Global CGRP Targeting Drugs for Migraine Market: Hospital (2021-2026) & ($ millions)
Figure 12. CGRP Targeting Drugs for Migraine in Specialty Clinic
Figure 13. Global CGRP Targeting Drugs for Migraine Market: Specialty Clinic (2021-2026) & ($ millions)
Figure 14. CGRP Targeting Drugs for Migraine in Others
Figure 15. Global CGRP Targeting Drugs for Migraine Market: Others (2021-2026) & ($ millions)
Figure 16. Global CGRP Targeting Drugs for Migraine Market Size Market Share by Application in 2025
Figure 17. Global CGRP Targeting Drugs for Migraine Revenue Market Share by Player in 2025
Figure 18. Global CGRP Targeting Drugs for Migraine Market Size Market Share by Region (2021-2026)
Figure 19. Americas CGRP Targeting Drugs for Migraine Market Size 2021-2026 ($ millions)
Figure 20. APAC CGRP Targeting Drugs for Migraine Market Size 2021-2026 ($ millions)
Figure 21. Europe CGRP Targeting Drugs for Migraine Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size 2021-2026 ($ millions)
Figure 23. Americas CGRP Targeting Drugs for Migraine Value Market Share by Country in 2025
Figure 24. United States CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC CGRP Targeting Drugs for Migraine Market Size Market Share by Region in 2025
Figure 29. APAC CGRP Targeting Drugs for Migraine Market Size Market Share by Type (2021-2026)
Figure 30. APAC CGRP Targeting Drugs for Migraine Market Size Market Share by Application (2021-2026)
Figure 31. China CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 35. India CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe CGRP Targeting Drugs for Migraine Market Size Market Share by Country in 2025
Figure 38. Europe CGRP Targeting Drugs for Migraine Market Size Market Share by Type (2021-2026)
Figure 39. Europe CGRP Targeting Drugs for Migraine Market Size Market Share by Application (2021-2026)
Figure 40. Germany CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 41. France CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 42. UK CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size Market Share by Application (2021-2026)
Figure 48. Egypt CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries CGRP Targeting Drugs for Migraine Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 54. APAC CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 55. Europe CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 57. United States CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 58. Canada CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 59. Mexico CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 60. Brazil CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 61. China CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 62. Japan CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 63. Korea CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 65. India CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 66. Australia CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 67. Germany CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 68. France CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 69. UK CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 70. Italy CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 71. Russia CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 72. Egypt CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 73. South Africa CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 74. Israel CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 75. Turkey CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)
Figure 76. Global CGRP Targeting Drugs for Migraine Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global CGRP Targeting Drugs for Migraine Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries CGRP Targeting Drugs for Migraine Market Size 2027-2032 ($ millions)